SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences informs about demise of director

02 Apr 2024 Evaluate
Gufic Biosciences has informed about the sad demise of Shrirang Vaidya (DIN: 03618800), Independent Director of the Company on April 1, 2024. His sudden and unexpected passing away will be an irreparable loss to the Company and all the directors and employees of the Company convey deep sympathy, sorrow and condolences to his family. Further, informed that he would be ceased to be the Chairman of Audit Committee and Nomination and Remuneration Committee and Member of Risk Management Committee of the Company. The details as required under Regulation 30 of SEBI Listing Regulations read with SEBI Circular No.   SEBI/HO/CFD/CFD?PoD?1/P/CIR/2023/123 dated July 13, 2023 is as enclosed.

The above information is a part of company’s filings submitted to BSE.

Gufic Biosciences Share Price

306.05 4.85 (1.61%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×